Loading...

We've got a brand new version of Simply Wall St! Try it out

Vitro. de

OTCPK:VITO.F
Snowflake Description

Undervalued with excellent balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
VITO.F
OTCPK
MX$20B
Market Cap
  1. Home
  2. US
  3. Materials
Company description

Vitro, S. A. B. de C. V., through its subsidiaries, designs, manufactures, processes, distributes, and markets a range of glass products worldwide. The last earnings update was 23 days ago. More info.


Add to Portfolio Compare Print
VITO.F Share Price and Events
7 Day Returns
0%
OTCPK:VITO.F
-0.6%
US Packaging
-1%
US Market
1 Year Returns
-
OTCPK:VITO.F
3.9%
US Packaging
-0.4%
US Market
VITO.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Vitro. de (VITO.F) 0% -13.5% - - -36.1% -20%
US Packaging -0.6% -1.2% 1.7% 3.9% 16% 29.2%
US Market -1% -3.3% 0.4% -0.4% 30.4% 37.1%
1 Year Return vs Industry and Market
  • No trading data on VITO.F.
  • No trading data on VITO.F.
Price Volatility
VITO.F
Industry
5yr Volatility vs Market
Related Companies

VITO.F Value

 Is Vitro. de undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Vitro. de to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Vitro. de.

OTCPK:VITO.F Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9.4%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:VITO.F
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Packaging Unlevered Beta Simply Wall St/ S&P Global 0.8
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.803 (1 + (1- 30%) (68.66%))
1.127
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.13
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.127 * 5.96%)
9.45%

Discounted Cash Flow Calculation for OTCPK:VITO.F using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Vitro. de is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

OTCPK:VITO.F DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 9.45%)
2020 173.00 Analyst x1 158.07
2021 249.00 Analyst x1 207.87
2022 303.00 Analyst x1 231.12
2023 330.00 Analyst x1 229.99
2024 352.42 Est @ 6.79% 224.42
2025 372.07 Est @ 5.58% 216.48
2026 389.64 Est @ 4.72% 207.14
2027 405.71 Est @ 4.12% 197.06
2028 420.74 Est @ 3.71% 186.73
2029 435.10 Est @ 3.41% 176.43
Present value of next 10 years cash flows $2,035.31
OTCPK:VITO.F DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $435.10 × (1 + 2.73%) ÷ (9.45% – 2.73%)
$6,655.20
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $6,655.20 ÷ (1 + 9.45%)10
$2,698.68
OTCPK:VITO.F Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $2,035.31 + $2,698.68
$4,734.00
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $4,734.00 / 476.03
$9.94
OTCPK:VITO.F Discount to Share Price
Calculation Result
Exchange Rate USD/MXN
(Reporting currency to currency of BMV:VITRO A)
19.564
Value per Share
(MXN)
= Value per Share in USD x Exchange Rate (USD/MXN)
= $9.94 x 19.564
MX$194.56
Non-primary Listing Adjustment Factor 1 share in OTCPK:VITO.F represents 0.04977x of BMV:VITRO A
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.04977x
Value per Share
(Listing Adjusted, USD)
= Value per Share (MXN) x Listing Adjustment Factor
= MX$ 194.56 x 0.04977
$9.68
Value per share (USD) From above. $9.68
Current discount Discount to share price of $2.12
= -1 x ($2.12 - $9.68) / $9.68
78.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Vitro. de is available for.
Intrinsic value
>50%
Share price is $2.12 vs Future cash flow value of $9.68
Current Discount Checks
For Vitro. de to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Vitro. de's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Vitro. de's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Vitro. de's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Vitro. de's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:VITO.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in USD $0.32
BMV:VITRO A Share Price ** BMV (2019-08-07) in MXN MX$42.6
BMV:VITRO A Share Price converted to USD reporting currency Exchange rate (MXN/ USD) 0.051 $2.18
United States of America Packaging Industry PE Ratio Median Figure of 15 Publicly-Listed Packaging Companies 16.87x
United States of America Market PE Ratio Median Figure of 3,095 Publicly-Listed Companies 17.23x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Vitro. de.

OTCPK:VITO.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BMV:VITRO A Share Price ÷ EPS (both in USD)

= 2.18 ÷ 0.32

6.83x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Vitro. de is good value based on earnings compared to the US Packaging industry average.
  • Vitro. de is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does Vitro. de's expected growth come at a high price?
Raw Data
OTCPK:VITO.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 6.83x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
17.4%per year
United States of America Packaging Industry PEG Ratio Median Figure of 15 Publicly-Listed Packaging Companies 1.26x
United States of America Market PEG Ratio Median Figure of 2,124 Publicly-Listed Companies 1.4x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Vitro. de, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Vitro. de's assets?
Raw Data
OTCPK:VITO.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in USD $3.05
BMV:VITRO A Share Price * BMV (2019-08-07) in MXN MX$42.6
BMV:VITRO A Share Price converted to USD reporting currency Exchange rate (MXN/ USD) 0.051 $2.18
United States of America Packaging Industry PB Ratio Median Figure of 20 Publicly-Listed Packaging Companies 3.4x
United States of America Market PB Ratio Median Figure of 5,265 Publicly-Listed Companies 1.7x
OTCPK:VITO.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BMV:VITRO A Share Price ÷ Book Value per Share (both in USD)

= 2.18 ÷ 3.05

0.71x

* Primary Listing of Vitro. de.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Vitro. de is good value based on assets compared to the US Packaging industry average.
X
Value checks
We assess Vitro. de's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Packaging industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Packaging industry average (and greater than 0)? (1 check)
  5. Vitro. de has a total score of 5/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

VITO.F Future Performance

 How is Vitro. de expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

  • No analysts cover Vitro. de, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
17.4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Vitro. de expected to grow at an attractive rate?
  • Vitro. de's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Vitro. de's earnings growth is expected to exceed the United States of America market average.
  • Vitro. de's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
OTCPK:VITO.F Future Growth Rates Data Sources
Data Point Source Value (per year)
OTCPK:VITO.F Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 17.4%
OTCPK:VITO.F Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 4.4%
United States of America Packaging Industry Earnings Growth Rate Market Cap Weighted Average 15.4%
United States of America Packaging Industry Revenue Growth Rate Market Cap Weighted Average 3.3%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:VITO.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:VITO.F Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 2,788 1
2022-12-31 2,710 1
2021-12-31 2,622 1
2020-12-31 2,545 1
2019-12-31 2,424 1
OTCPK:VITO.F Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-06-30 2,235 145 148
2019-03-31 2,236 202 119
2018-12-31 2,238 222 162
2018-09-30 2,225 265 176
2018-06-30 2,208 318 178
2018-03-31 2,202 317 214
2017-12-31 2,075 294 194
2017-09-30 1,958 327 208
2017-06-30 1,634 315 204
2017-03-31 1,266 299 199
2016-12-31 963 271 176
2016-09-30 839 265 145

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Vitro. de's earnings are expected to grow by 17.4% yearly, however this is not considered high growth (20% yearly).
  • Vitro. de's revenue is expected to grow by 4.4% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:VITO.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Vitro. de Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:VITO.F Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
OTCPK:VITO.F Past Financials Data
Date (Data in USD Millions) EPS *
2019-06-30 0.32
2019-03-31 0.25
2018-12-31 0.34
2018-09-30 0.36
2018-06-30 0.36
2018-03-31 0.45
2017-12-31 0.40
2017-09-30 0.43
2017-06-30 0.42
2017-03-31 0.41
2016-12-31 0.36
2016-09-30 0.30

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Vitro. de is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Vitro. de's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Vitro. de has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

VITO.F Past Performance

  How has Vitro. de performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Vitro. de's growth in the last year to its industry (Packaging).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Vitro. de has delivered over 20% year on year earnings growth in the past 5 years.
  • Vitro. de's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Vitro. de's 1-year earnings growth is negative, it can't be compared to the US Packaging industry average.
Earnings and Revenue History
Vitro. de's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Vitro. de Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:VITO.F Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 2,234.60 147.93 359.92
2019-03-31 2,236.07 118.60 362.63
2018-12-31 2,238.38 161.74 373.61
2018-09-30 2,224.77 175.96 361.35
2018-06-30 2,207.99 177.98 373.45
2018-03-31 2,201.96 213.58 372.36
2017-12-31 2,075.23 193.79 350.99
2017-09-30 1,958.25 208.22 341.69
2017-06-30 1,634.38 203.71 282.07
2017-03-31 1,265.95 199.30 220.32
2016-12-31 963.13 175.64 162.72
2016-09-30 838.96 145.28 142.80
2016-06-30 864.54 33.86 149.73
2016-03-31 884.32 -10.14 153.71
2015-12-31 819.98 -69.65 143.02
2015-09-30 763.05 -132.69 156.64
2015-06-30 753.61 -94.83 157.73
2015-03-31 744.56 -93.15 161.71
2014-12-31 755.00 -87.32 161.16
2014-09-30 1,015.38 -50.43 172.53
2014-06-30 1,268.80 11.20 208.35
2014-03-31 1,468.49 -17.59 238.70
2013-12-31 1,645.69 44.47 273.93
2013-09-30 1,666.72 -265.55 280.40
2013-06-30 1,712.96 -260.08 292.49
2013-03-31 1,845.20 -273.68 313.82
2012-12-31 1,780.38 262.07 299.81
2012-09-30 1,782.18 586.46 319.79

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Vitro. de has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Vitro. de used its assets more efficiently than the US Packaging industry average last year based on Return on Assets.
  • Vitro. de's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Vitro. de's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Packaging industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Vitro. de has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

VITO.F Health

 How is Vitro. de's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Vitro. de's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Vitro. de is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Vitro. de's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Vitro. de's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Vitro. de Company Filings, last reported 1 month ago.

OTCPK:VITO.F Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 1,451.09 662.45 121.24
2019-03-31 1,440.55 663.26 176.81
2018-12-31 1,468.26 720.89 290.97
2018-09-30 1,508.99 687.11 105.68
2018-06-30 1,421.96 687.91 128.15
2018-03-31 1,438.23 688.94 160.01
2017-12-31 1,385.04 689.47 180.48
2017-09-30 1,431.06 747.76 213.50
2017-06-30 1,371.98 747.90 173.60
2017-03-31 1,286.19 742.73 188.87
2016-12-31 1,199.83 513.85 240.69
2016-09-30 1,166.42 497.86 925.30
2016-06-30 1,173.15 0.00 424.61
2016-03-31 1,211.21 0.36 444.05
2015-12-31 1,169.23 0.00 414.26
2015-09-30 1,160.54 1.26 505.95
2015-06-30 565.86 1,148.91 150.17
2015-03-31 539.68 1,177.65 169.81
2014-12-31 546.90 1,186.53 167.39
2014-09-30 645.77 1,241.36 236.10
2014-06-30 662.49 1,257.45 218.70
2014-03-31 626.48 1,258.11 209.27
2013-12-31 488.02 1,261.97 168.02
2013-09-30 499.56 1,254.39 184.69
2013-06-30 476.16 1,405.50 265.09
2013-03-31 523.92 1,177.61 203.58
2012-12-31 396.56 1,151.87 188.65
2012-09-30 720.25 1,148.93 192.66
  • Vitro. de's level of debt (45.7%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (189.8% vs 45.7% today).
  • Debt is well covered by operating cash flow (21.9%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 6.2x coverage).
X
Financial health checks
We assess Vitro. de's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Vitro. de has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

VITO.F Dividends

 What is Vitro. de's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
4.79%
Current annual income from Vitro. de dividends.
If you bought $2,000 of Vitro. de shares you are expected to receive $96 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Vitro. de's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.49%).
  • Vitro. de's dividend is above the markets top 25% of dividend payers in United States of America (3.84%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:VITO.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
United States of America Packaging Industry Average Dividend Yield Market Cap Weighted Average of 13 Stocks 2.6%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2009 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:VITO.F Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
OTCPK:VITO.F Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-04-30 0.104 4.214
2019-02-22 0.104 4.021
2019-02-19 0.104 3.842
2018-07-27 0.065 2.349
2018-02-27 0.065 2.085
2018-02-19 0.065 1.757
2017-07-26 0.052 1.321
2017-03-30 0.052 1.263
2017-02-22 0.052 1.388
2016-04-29 1.600 51.142
2016-04-14 1.600 47.834
2015-10-28 3.108 101.243
2010-01-15 0.000 0.000
2009-10-30 0.000 0.000
2009-10-28 0.000 0.000
2009-07-29 0.000 0.000
2009-07-01 0.000 0.000
2008-12-31 0.000 0.000

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Vitro. de has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Vitro. de has only been paying a dividend for 4 years, and since then dividends per share have fallen.
Current Payout to shareholders
What portion of Vitro. de's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3.1x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Vitro. de's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Vitro. de afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Vitro. de has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

VITO.F Management

 What is the CEO of Vitro. de's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Adrian G. Sada Cueva
AGE 44
TENURE AS CEO 6.4 years
CEO Bio

Mr. Adrian G. Sada Cueva serves as the Chief Executive Officer. Mr. Sada Cueva has been Chief Executive Officer of Vitro, S.A.B. de C.V. since March 20, 2013. He serves as Vice President of Administration & Finance of Vitro’s Glasss Containers Business Unit. He served as the President at Compania Vidriera, S.A. de C.V. He served as the President of The Glass Containers Business Unit at Vitro, S.A.B. de C.V. from 2012 to 2013. At Vitro, he served as the President of Envases from 2012 to 2013, Operating Director of Envases from 2011, Director General of Administration & Finance of Envases from 2009 to 2010. He served as General Manager of Vitro Automotriz from 2006 to 2008. He served as the President of Compañía Vidriera, S.A. De C.V. He has been a Director of Vitro, S.A.B. de C.V from 2010. He has been an Independent Director at Nemak, S.A.B. de C.V. (Also known as: Tenedora Nemak, S.A. de C.V.) from June 2015. He has also served as Director of Vitro Cristalglass (Spain), Managing Director of Vitro Automotriz, Director of Internal Restructuring, Director of Administration and Finance and Managing Director of Vitro’s packaging business. He has been an Independent Director of Grupo Financiero Banorte, S.A.B. de C.V. from April 2013. He serves as a Director of Club Industrial de Monterrey, Banco Mercantil del Norte, CAINTRA Nuevo León, Club Deportivo Cazadores Monterrey, Empresas Comegua S.A., Confederación Patronal de la República Mexicana (Coparmex) Nuevo León, Consejo General de la Universidad de Monterrey, Pronatura Noreste A.C., Organización Vida Silvestre A.C. and Salinas del Pacífico, S.A. de C.V. He is a Board Member at Cámara de la Industria de Transformación (CAINTRA) of Nuevo León. He is also a Member of The Boards of Directors of Civil Associations, Wildlife Organization and Salinas of The Pacific. He served as a Board Member Compañía Minera Autlán, S.A.B. de C.V. since 2017. Mr. Sada Cueva has a degree in Business Administration from ITESM and obtained an MBA from Stanford Graduate School of Business.

CEO Compensation
  • Insufficient data for Adrian G. to compare compensation growth.
  • Insufficient data for Adrian G. to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Vitro. de management team in years:

12.3
Average Tenure
62
Average Age
  • The average tenure for the Vitro. de management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Claudio Del Valle Cabello

TITLE
Chief Administrative & Financial Officer
AGE
59
TENURE
16.6 yrs

Adrian G. Sada Cueva

TITLE
CEO & Director
AGE
44
TENURE
6.4 yrs

Adrián Meouchi

TITLE
Vice President of Investor Relations

Alejandro Francisco Sánchez Mújica

TITLE
Secretary of the Board
AGE
65
TENURE
12.3 yrs

Raúl Rangel Hinojosa

TITLE
Legal & Financial Advisor
AGE
70
Board of Directors Tenure

Average tenure and age of the Vitro. de board of directors in years:

11.6
Average Tenure
66
Average Age
  • The average tenure for the Vitro. de board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Adrián G. Sada González

TITLE
Chairman of the Board
AGE
75

Adrian G. Sada Cueva

TITLE
CEO & Director
AGE
44
TENURE
9.6 yrs

Joaquín Vargas Guajardo

TITLE
Director
AGE
65
TENURE
19.6 yrs

Tomás Roberto González Sada

TITLE
Director
AGE
76
TENURE
39.6 yrs

Jaime José Serra Puche

TITLE
Director
AGE
68
TENURE
21.6 yrs

Ricardo Martin Bringas

TITLE
Director
AGE
59
TENURE
12.6 yrs

Jaime Rico Garza

TITLE
Director
AGE
62
TENURE
11.6 yrs

Guillermo Martínez

TITLE
Director
AGE
71
TENURE
9.6 yrs

Mario Martín Laborín Gómez

TITLE
Director
AGE
67
TENURE
9.6 yrs

Álvaro Fernández Garza

TITLE
Director
AGE
51
TENURE
8.6 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Vitro. de's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Vitro. de has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

VITO.F News

Simply Wall St News

VITO.F Company Info

Description

Vitro, S. A. B. de C. V., through its subsidiaries, designs, manufactures, processes, distributes, and markets a range of glass products worldwide. It operates in two segments, Flat Glass and Glass Containers. The Flat Glass segment provides flat glass products for the construction and automotive industries; and carbonate and sodium bicarbonate. The Glass Containers segment offers glass containers for the cosmetics, fragrances and toiletries, and pharmaceuticals markets; and precision components, as well as machineries and molds for the glass industry. In addition, it provides chemical products and raw materials for use in the glass, detergents, water treatment, oil, roads and highway thawing, food, and poultry and livestock markets; and provides engineering, automation, and other services. Vitro, S. A. B. de C. V. was founded in 1909 and is based in San Pedro Garza García, Mexico.

Details
Name: Vitro, S.A.B. de C.V.
VITO.F
Exchange: OTCPK
Founded: 1909
MX$1,036,541,725
476,033,004
Website: http://www.vitro.com
Address: Vitro, S.A.B. de C.V.
Avenida Ricardo Margáin Zozaya No. 400,
Colonia Valle del Campestre,
San Pedro Garza García,
Nuevo Leon, 66265,
Mexico
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BMV VITRO A Series A Common Stock Bolsa Mexicana de Valores MX MXN 21. Aug 1991
OTCPK VITO.F Series A Common Stock Pink Sheets LLC US USD 21. Aug 1991
Number of employees
Current staff
Staff numbers
15,243
Vitro. de employees.
Industry
Metal and Glass Containers
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/08/17 23:50
End of day share price update: 2019/08/07 00:00
Last estimates confirmation: 2019/03/06
Last earnings filing: 2019/07/25
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.